Related Experiment Videos

Single-dose antibiotic treatment for symptomatic urinary tract infections in women: a meta-analysis of randomized

L Leibovici1, A J Wysenbeek

  • 1Department of Internal Medicine B, Beilinson Medical Center, Petah Tiqva, Israel.

Insights

Single-dose antibiotics are less effective for treating urinary tract infections in women compared to conventional therapy, with higher cure rates seen in longer treatment courses. However, single-dose regimens result in fewer side effects.

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Women's Health

Background:

  • Urinary tract infections (UTIs) are common in women.
  • Treatment options include single-dose and conventional multi-day antibiotic regimens.
  • Assessing the comparative efficacy and safety of these regimens is crucial for optimal patient care.

Purpose of the Study:

  • To compare the efficacy of single-dose antibiotic therapy versus conventional therapy for symptomatic UTIs in women.
  • To analyze cure rates at different post-treatment intervals (3-14 days and 4-6 weeks).
  • To evaluate the safety profile, specifically the incidence of side-effects, for both treatment approaches.

Main Methods:

  • A meta-analysis of 25 controlled studies was conducted.
  • Efficacy was assessed by comparing cure rates between single-dose and conventional therapy groups.
  • Statistical analysis included calculating odds ratios and 95% confidence intervals.

Main Results:

  • Single-dose antibiotics showed lower efficacy than conventional therapy at both 3-14 days (OR 0.5, 95% CI 0.4-0.7) and 4-6 weeks (OR 0.4, 95% CI 0.3-0.6).
  • This trend persisted even when bacterial isolates were sensitive to the prescribed drug.
  • Single-dose regimens were associated with significantly fewer side-effects (OR 0.5, 95% CI 0.4-0.6).

Conclusions:

  • Conventional antibiotic therapy is generally more effective for treating UTIs in women than single-dose regimens.
  • While single-dose trimethoprim/sulphamethoxazole may be less effective, it offers a benefit of reduced side-effects.
  • The choice between single-dose and conventional therapy should involve a cost-benefit analysis specific to the healthcare system.

Related Concept Videos